Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for amlodipine benzenesulfonate tablets
Announcement of Yiping Hong (300723.SZ): The company's wholly-owned subsidiary, Guangzhou Yiping Hong Pharmaceutical Co., Ltd., recently received a notification from the country...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the amlodipine besylate tablet. Indications for amlodipine besylate tablets include: hypertension and coronary artery disease (CAD).
Related Articles

Macau Gaming Holdings (00880) plans to acquire $500 million in cash for the preferential notes maturing in 2026, and simultaneously promote the issuance of new notes.

COLOUR LIFE (01778) plans to conduct a stock restructuring. The stake held by Huayuan Nian will decrease to approximately 9.98%.

SJM Holdings (00880) is planning to issue U.S. dollar-denominated preferred notes.
Macau Gaming Holdings (00880) plans to acquire $500 million in cash for the preferential notes maturing in 2026, and simultaneously promote the issuance of new notes.

COLOUR LIFE (01778) plans to conduct a stock restructuring. The stake held by Huayuan Nian will decrease to approximately 9.98%.

SJM Holdings (00880) is planning to issue U.S. dollar-denominated preferred notes.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


